CONTACT
|
PROVIDER PORTAL
|
PROVIDER SEARCH
|
REIMBURSEMENT
INDICATIONS
Musculoskeletal
SoftWave Wound Care
Wound Case Study
ABOUT
SoftWave Technology
OrthoGold 100®
UroGold100
DermaGold 100®
Shockwave Therapy
ABOUT US
BOARD
Privacy Policy
News & Press Releases
FDA Clearances
Softwave Blog
FAQs
Events
RESEARCH
Pain/Sports Med/Regenerative Research Library
Urology Research Library
Podiatry Research Library
Wound/Burn Research Library
PATIENTS
BECOME A PROVIDER
DISTRIBUTORS
CONTACT US
Contact Us
PROVIDERS SEARCH
CONTACT
|
PROVIDER PORTAL
|
PROVIDER SEARCH
|
REIMBURSEMENT
INDICATIONS
Musculoskeletal
SoftWave Wound Care
Wound Case Study
ABOUT
SoftWave Technology
OrthoGold 100®
UroGold100
DermaGold 100®
Shockwave Therapy
ABOUT US
BOARD
Privacy Policy
News & Press Releases
FDA Clearances
Softwave Blog
FAQs
Events
RESEARCH
Pain/Sports Med/Regenerative Research Library
Urology Research Library
Podiatry Research Library
Wound/Burn Research Library
PATIENTS
BECOME A PROVIDER
DISTRIBUTORS
CONTACT US
Contact Us
PROVIDERS SEARCH
Home
Protocols
Service/Troubleshooting
Marketing
Clinical Docs
FAQ
Products/Refurb
Cart
Contact Us
Logout
Extracorporeal shockwave therapy (ESWT) minimizes ischemic tissue necrosis irrespective of application time and promotes tissue revascularization by stimulating angiogenesis
SoftWave Literature
Mittermayer R, Hartinger J, Antonic V, et al.
Ann Surg.
2011; 253(5):1024-32
Click here to read more.
0
Shares
Prev
Next
Related Posts
Alternatives to Surgery
Blog
,
Uncategorized
Alternatives to Cortisone Shots
Blog
Using Sound to Battle Opioid Crisis
Blog
